Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breakthrough Pain × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 36 Thyroid Neoplasms 17 Thyroid Nodule 7 Mouth Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Thyroid Diseases 4 Pain, Postoperative 4 Lung Neoplasms 4 Goiter 4 Parathyroid Neoplasms 3 Pancreatic Neoplasms 3 Oropharyngeal Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Neoplasms 3 Mucositis 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tobacco Use Disorder 2 Thyroid Cancer, Papillary 2 Stomatitis 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Parathyroid Diseases 2 Nasopharyngeal Carcinoma 2 Malnutrition 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2

Interventions

Morphine 1 Gastrostomy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡